speaker-photo

Dr. Mohammed Yassin 🇶🇦

Professor of Hematology and Head of Hematology at Hamad Medical Corporation (HMC)

03:00 - 03:20

Day3 Day3-Trak2

Advances in Targeted and JAK2 Inhibition Therapy in MPNs